I

IOVA

IOVA

UnknownUnknown

Company information not available. Track real-time insider trading activity, SEC Form 4 filings, and executive stock transactions.

Insider Sentiment
Based on recent trading activity
43%Neutral
Buy/Sell Ratio100% buys
BearishBullish
IOVA Live QuoteReal-time
$7.31
$7.31(-50.00%)1M
Day Range$7.28 – $7.70
Open$7.54
Previous Close$7.48
Volume8.53M
Key Financials & Valuation
Fundamental balance sheet & market metrics
HEALTHCARE
Market Cap$3.43B
P/E Ratio (TTM)24.5
Forward P/ENaN
EPS (TTM)$-0.49
Price to Book4.3
Dividend Yield0.65%
Beta (Volatility)0.84
IndustryBIOTECHNOLOGY
52-Week RangeCurrent: $7.31 (39%)
Low: $2.08High: $15.37
Wall Street Consensus
Sell
Analyst Rating
2.2/ 5.0
Target Price
$14.50-90.3% upside

Insider Buys

3

$107K

Insider Sales

0

$0

Total Volume

$107K

7 transactions

Net Activity

+$107K

Net buying

Proprietary Ratings
Calculated from Form 4 transactions
100CONFIDENCE

Sentiment Rating

Strong Accumulation

CEO Conviction Index

High Conviction Accumulation

Key Drivers

  • •Strong buying bias: purchases represent 100% of total transaction value.
  • •Cluster buying: 3 unique insiders purchased shares, showing strong alignment.
  • •CEO buying activity detected. When chief executives put their own money at risk, it is historically a strong bullish signal.
Score Methodology

The Insider Confidence Score (1-100) measures executive conviction. Starting from a neutral 50, it adjusts based on:

  • +15Strong Buy Ratio: Purchases > 70% of volume (or up to -15 for heavy sales).
  • +20Cluster Buying: ≥3 unique insiders buying within a 30-day window.
  • +15CEO Buying: CEO committing own capital shows high conviction.
  • +10CFO Buying: CFO purchasing shares shows financial alignment.
Top Insiders
Most active traders
M
1

Multiple Insiders

P - Purchase Insiders

0 buys4 sells

$11.42B total

K
2

Kirby Daniel Gordon

Chief Commercial Officer

1 buys0 sells

$55K total

V
3

Vogt Frederick G

Interim CEO, GC

1 buys0 sells

$42K total

P
4

Puri Raj K.

Chief Regulatory Officer

1 buys0 sells

$10K total

Trading History
IOVA insider transactions from SEC Form 4 filings
DateInsiderTypeSharesPriceValueFiling

Jun 5, 2025

17 months ago

Multiple Insiders

P - Purchase Insiders

Insider
Sell30.0K$30000.00$900.00M

Jun 5, 2025

17 months ago

Kirby Daniel Gordon

Chief Commercial Officer

C-Level
Buy30.0K$1.84$55K

May 23, 2025

18 months ago

Multiple Insiders

P - Purchase Insiders

Insider
Sell206.9K$5600.00$1.16B

May 23, 2025

18 months ago

Puri Raj K.

Chief Regulatory Officer

C-Level
Buy5.6K$1.74$10K

May 14, 2025

18 months ago

Vogt Frederick G

Interim CEO, GC

CEO
Buy25.0K$1.69$42K

May 14, 2025

18 months ago

Multiple Insiders

P - Purchase Insiders

Insider
Sell374.6K$25000.00$9.37B

Nov 12, 2024

24 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell7.5K$-50000.00$0
Sector & Industry Benchmarks
Unknown Comparison Overview
Industry Buy Conviction6%
IOVA Buy Conviction100%
Industry Rank#0 of 570
Volume Contribution0.0%
Total Industry Activity$16.44B

IOVA has an insider buy conviction of 100%, compared to the Unknown sector buy average of 6%.

Insider Trading Summary & Commentary
Automated executive transaction analysis for IOVA

Over the last 90 days, corporate insiders at IOVA (IOVA) engaged in a total of 7 transactions reported via SEC Form 4 filings. Among these, 3 were open-market purchases and 0 were sales. The total volume of insider trading reached $107K.

The net insider activity for IOVA shows a net buying bias of $107K. This activity represents a 100% buy ratio, suggesting that insiders are currently strongly bullish on the company's near-term outlook relative to recent history.

The most notable individual transaction was a Sale by Multiple Insiders (P - Purchase Insiders), who traded 374.6K shares valued at $9.37B on May 14, 2025.

Live Market News & Developments
Aggregated real-time headlines for IOVA (IOVA)
6 updates

Is 50% Crash Risk For Iovance Stock Real?

Yahoo Finance20d ago

Can Iovance Stock Fall 50%?

Trefis21d ago

Iovance, A Top 1% Biotech Stock, Crashes In A Surprise Lung Cancer Twist

Investor's Business Daily20d ago

IOVA Stock: Can Cell Therapy Deliver Commercial Growth for Iovance?

CMC Markets36d ago

Iovance Biotherapeutics (IOVA) Stock Gets Fair Value Boost On Amtagvi Demand And Margin Outlook

Yahoo Finance47d ago

Iovance: Buy Now Before Many Growth Catalysts Kick In (NASDAQ:IOVA)

Seeking Alpha45d ago

FAQs About IOVA Insider Trading

Answers to common questions regarding corporate filings and executive sentiment for IOVA.

Based on SEC Form 4 disclosures, the Insider Confidence Score for IOVA is currently 100/100, which reflects a strong accumulation bias. This calculation accounts for a total of 3 purchases and 0 sales by company executives over the last 90 days.

The CEO Conviction Index for IOVA is rated as "High Conviction Accumulation". Executive buying is typically a strong vote of confidence as C-level leaders have the most intimate knowledge of their firm's prospects. Officer selling, on the other hand, is often routine and does not automatically signal operational weakness.

No. Insider tracking is a highly informative technical signal that indicates executive sentiment, but it should not be the sole basis for a transaction. Investors should combine this filing analysis with company financials, sector trends, and risk management criteria.